Abbott Laboratories (BCBA:ABT)

Market Cap	305.58T
Revenue (ttm)	60.09T
Net Income (ttm)	19.09T
Shares Out	n/a
EPS (ttm)	10,910.24
PE Ratio	16.01
Forward PE	21.92
Dividend	452.09 (0.95%)
Ex-Dividend Date	Oct 15, 2025

Volume	586
Average Volume	902
Open	47,300
Previous Close	47,000
Day's Range	46,860 - 47,420
52-Week Range	30,325 - 53,525
Beta	n/a
RSI	41.88
Earnings Date	Jan 22, 2026

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD